Maze Therapeutics, Inc. (MAZE) Insider Trading
Over the last 3 months, MAZE insiders made 0 open-market buys and 15 sales, a net sale of -$3.0M (SEC Form 4). Over the last 6 months, 109 institutions increased and 55 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
15
Net (3m)
-$3.0M
Insider trades by month Buys Sells
Jan
Feb
Mar
Apr
May
Jun
Context3-month price +0%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 24, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 23,865 | $26.05 |
| Jun 24, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 1,953 | $26.00 |
| Jun 24, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 2,040 | $26.00 |
| Jun 10, 2026 | Lim Jonathan Edirector | Grant | 18,000 | $23.58 |
| Jun 10, 2026 | Hoppenot Hervedirector | Grant | 18,000 | $23.58 |
| Jun 10, 2026 | HOMCY CHARLES Jdirector | Grant | 18,000 | $23.58 |
| Jun 10, 2026 | Andrews Nancy Cdirector | Grant | 18,000 | $23.58 |
| Jun 10, 2026 | SPIEGELMAN DANIEL Kdirector | Grant | 18,000 | $23.58 |
| Jun 10, 2026 | SCHELLER RICHARD Hdirector | Grant | 18,000 | $23.58 |
| Jun 3, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 6,090 | $26.20 |
| Jun 3, 2026 | Bernstein Haroldofficer: President, R&D & CMO | Sell | 1,600 | $26.36 |
| Jun 3, 2026 | Bernstein Haroldofficer: President, R&D & CMO | Sell | 13,253 | $25.57 |
| Jun 3, 2026 | Bernstein Haroldofficer: President, R&D & CMO | Option | 14,853 | $10.42 |
| Jun 3, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 553 | $26.24 |
| Jun 2, 2026 | Dandekar Atulofficer: CSBO | Option | 7,500 | $10.42 |
| Jun 2, 2026 | Dandekar Atulofficer: CSBO | Sell | 7,500 | $26.34 |
| May 27, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 4,504 | $26.00 |
| May 27, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 2,478 | $26.00 |
| May 27, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 25,582 | $26.02 |
| May 18, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 1,822 | $26.00 |
| May 18, 2026 | Bernstein Haroldofficer: President, R&D & CMO | Option | 15,000 | $10.42 |
| May 18, 2026 | Bernstein Haroldofficer: President, R&D & CMO | Sell | 15,000 | $26.22 |
| May 18, 2026 | Coloma Jason Vdirector, officer: Chief Executive Officer | Sell | 116 | $26.00 |
| May 6, 2026 | Dandekar Atulofficer: CSBO | Option | 5,985 | $10.42 |
| May 6, 2026 | Dandekar Atulofficer: CSBO | Option | 8,320 | $10.42 |
| May 1, 2026 | Dandekar Atulofficer: CSBO | Sell | 7,500 | $25.37 |
| May 1, 2026 | Dandekar Atulofficer: CSBO | Option | 7,500 | $10.42 |
| Apr 2, 2026 | Bernstein Haroldofficer: President, R&D & CMO | Sell | 3,348 | $30.06 |
| Apr 2, 2026 | Bachrodt Amyofficer: SVP, Finance | Sell | 300 | $30.34 |
| Apr 2, 2026 | Bachrodt Amyofficer: SVP, Finance | Sell | 2,200 | $29.32 |
Source: MAZE SEC Form 4 filings, latest Jun 24, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their MAZE positions over the last 6 months (SEC Form 13F).
Increased
109
New positions
109
Reduced
55
Sold out
32
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | Increased | 5.7M | May 18, 2026 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | Unchanged | 4.6M | Feb 13, 2026 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | Unchanged | 4.6M | May 15, 2026 |
| TRV GP IV, LLC | Unchanged | 4.5M | May 7, 2026 |
| TRV GP IV, LLC | Reduced | 4.5M | Feb 13, 2026 |
| DEEP TRACK CAPITAL, LP | Increased | 4.2M | Feb 13, 2026 |
| ARCH VENTURE MANAGEMENT, LLC | Unchanged | 4.1M | Feb 17, 2026 |
| ARCH VENTURE MANAGEMENT, LLC | Unchanged | 4.1M | May 15, 2026 |
| DEEP TRACK CAPITAL, LP | Reduced | 3.5M | May 15, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 3.1M | Feb 17, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2.9M | May 15, 2026 |
| PARADIGM BIOCAPITAL ADVISORS LP | New Position | 2.7M | May 15, 2026 |
| BLACKROCK, INC. | Increased | 2.6M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 2.3M | Feb 12, 2026 |
| AH CAPITAL MANAGEMENT, L.L.C. | Unchanged | 1.7M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.